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1. Introduction
  Breast cancer is a malignant tumor occurred in the mammary 
gland epithelial tissue, its clinical manifestations is associated with 
the stage of tumor. The incidence of breast cancer is increasing 
year by year, and the age tends to young women, which brings a 
serious threat to women’s physical and mental health. Breast cancer 
is characterized with high risk of recurrence and metastasis, despite 
the surgery, radiotherapy, chemotherapy and endocrine treatment 
have certain efficiency for early breast cancer, the prognosis remains 
poor[1-3]. Therefore, it is very urgent to find a new specific target 
molecule for breast cancer therapy. In recent years, gene therapy has 
attracted growing attention for breast cancer [4,5], such as survivin. 
As a member of the inhibitor of apoptosis (IAP) gene family, 
survivin is high expressed during fetal development and in most 
tumors, plays an important role in cell proliferation and apoptosis. 
In the present study, we constructed a survivin siRNA eukaryotic 
expression vector and transfected to breast cancer cell line MCF-7 
to investigate the interfering efficiency and the influence of survivin 
expression on the biological characteristics of breast cancer cells.
2. Materials and methods
2.1. Cell culture and transfection
  MCF-7 cells were provided by Cancer Hospital, Chinese Academy 
of Sciences and cultured in RPMI 1640 medium (Sigma, U.S.A.) 
supplemented with 10% fetal bovine serum (Gibco, U.S.A.), 
100 units/mL penicillin G (Sigma, U.S.A.) and 100 毺g/mL 
streptomycin (Sigma, U.S.A.). Cells were incubated in a humidified 
atmosphere with 5% CO2 at 37 曟. MCF-7 cells were transfected 
with pIRES2-EGFP-survivin siRNA plasmids using Lipofectamine 
2000 (Invitrogen) according to the manufacturer’s protocol. The 
expression of survivin was detected 48 h after transfection. pIRES2-
EGFP-survivin siRNA plasmids was designed and synthesized by 
Sangon Biotech.
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2.2. Western blot 
  MCF-7 cells were washed with cold PBS and collected in cell 
lysate buffer, then centrifuged in a micro centrifuge at 4 曟 for 30 
min to collect the supernatant. Protein concentrations were detected 
with the NanoDrop (Thermo). The cell lysate was boiled for 5 min 
in 1伊SDS sample buffer and subjected to SDS-polyacrylamide 
gel electrophoresis (PAGE), then transferred to a polyvinylidene 
difluoride membrane (Millipore) by a transfer apparatus at 280 mA 
for 2 h. After blocked with 5 % nonfat milk at room temperature 
for 3 h, the membranes were incubated with the primary antibody 
against survivin (anti-rabbit, 1:1 000; Abcam), or glyceraldehyde-3-
phosphate dehydrogenase GAPDH (anti-rabbit, 1:1 000; Santa Cruz) 
at 4 曟 overnight. After incubating with the horseradish peroxidase-
conjugated secondary antibody (HRP Goat to rabbit; Santa Cruz), 
the protein was visualized using ECL (Thermo Pierce). 
2.3. Realtime-PCR
  The mRNA expression of survivin was determined by real-
time PCR by SYBER Green Master Mix (Takara, Dalian, China) 
and detected with Applied Biosystems 7500 Fast Real-Time PCR 
System (Applied Biosystems, Carlsbad, USA). Total RNA was 
isolated from cells using the Trizol reagent (Life Technologies) 
according to the manufacturer’s instructions. Complementary DNA 
(cDNA) was synthesized from total RNA with reverse transcription 
Kit (Fermentas Life Sciences). Primer pairs for survivin: 
sense, 5’-GCATGGGTCCCCCGACGTTG-3’; antisense, 5’-
GCTCCGGCCAGAGGCCTCAA-3’. 毬-actin was amplified using 
the following primer: sense, 5’-CGTGAAAAGACCCAGATCA-3’; 
antisense, 5’-CACAGCCTGGATGGCTACGT-3’. The mRNA 
expression of survivin was normalized versus 毬-actin mRNA. The 
Ct value was quantified with the 2
-ΔΔCt method. 
2.4. Cell proliferation detection
  The MCF-7 cells were diluted into single cell suspensions and 
seeded in 96-well plates (1伊106 cells/well) with  100 毺L 1% FBS 
medium, replaced with 10% FBS medium 24 hours later. Then, 
10 毺L CCK8 solution was added into each well on 0 h, 2 h, 6 h, 12 
h, 24 h and 48 h. Air bubbles should be avoided producing during 
this process. The plates were incubated for 1-4 hours in the incubator. 
The absorbance was measured at 450 nm using a microplate reader. 
CCK-8 Kit was purchased from DOJINDO Company (Japan). 
2.5. Apoptosis assay 
  FITC Annexin V Apoptosis Detection Kit (BD Biosciences, USA) 
was employed to detect apoptosis of MCF-7 cells. The manual of the 
kit was strictly followed. Briefly, cells were collected and washed 
twice with cold PBS, and resuspended in binding buffer (1伊106 cells/
mL). Then, 100 毺L of MCF-7 cells was transferred to a new tube, 
5 毺L of FITC-conjugated Annexin V was added in and incubated 
for 15 min at room temperature in the dark. 5 毺L of propidium 
iodide was added without wash. The stained MCF-7 cells were 
diluted by the binding buffer and directly analyzed by FACSCalibur 
(BD Biosciences, USA) and analysis was performed with FlowJo 
(Treestar, Ashland, OR).Viable cells and apoptotic cells were defined 
as annexin 桋 and PI double-negative and double-positive cells 
respectively.
2.6. Cell migration and invasion assays
  The potential for migration and invasion of MCF-7 cells transfected 
with pIRES2-EGFP-survivin siRNA were evaluated by a transwell 
assay. In the migration assay, 5伊104 cells were cultured in 200 mL 
DMEM with 1% bovine serum albumin in the upper chamber of a 
non-coated transwell insert. In the lower chamber, 600 mL DMEM 
with 10% FBS was used as a chemo-attractant to encourage cell 
migration. In the invasion assay, the upper chamber of the transwell 
inserts were coated with 50 毺L of 2.0 mg/mL Matrigel, and 5伊
104 cells were plated in the upper chamber of the Matrigel-coated 
transwell insert. After 24 h incubation, top (nonmigrated) cells 
were removed, and bottom (migrated) cells were fixed and stained 
with crystal violet and counted under an inverted microscope. We 
selected five random views to count the cells and the independent 
experiments were repeated three times.
2.7. Statistical analysis
  The data were expressed as mean依SD of 3 independent 
experiments and analyzed with SAS9.1.3 statistical software. The 
statistical significance of differences between groups was determined 
by one-way analysis of variance followed by Tukey’s post hoc 
multiple comparison tests. P<0.05 was considered significant.
3. Results
3.1. Expression of survivin in breast cancer cell lines
  Real time PCR was performed to investigate the expression of 
survivin in different breast cancer cell lines. High expression of 
survivin was found in MCF-7 cells, while survivin expressed 
relatively lower in MDA-MB-231, MDA-MB435, MDA-MB-468 
and SKBR3 cells (Figure 1).
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Figure 1. Expression of survivin in different breast cancer cell lines.
3.2. Efficiency of survivin siRNA in MCF-7 cells
  MCF-7 cells were transfected by survivin siRNA and control 
siRNA, and green fluorescence protein marker was observed by 
inverted fluorescence microscope at 48 h after transfection (Figure 
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3A, B). Real time PCR and Western blot results revealed that the 
mRNA level (Figure 3C) and protein level of survivin in MCF-7 cells 
transfected with survivin siRNA (Figure 3D) was dropped greatly, 
when compared with the control group. The expression of survivin 
in MCF-7 cells was effectively interfered by specific siRNA.
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Figure 2. Transfection efficiency of survivin siRNA in MCF-7 cells.
Green fluorescence was found in MCF-7 cells 48 h after transfected with 
Non-specific siRNA (A) and survivin siRNA (B); the mRNA (C) and protein 
(D) expression of survivin was detected by real time PCR and Western blot 
respectively. 
3.3. Change of MCF-7 cells proliferation and apoptosis after 
transfected with survivin siRNA 
  After transfected with non-specific siRNA and survivin siRNA, 
CCK8 and flow cytometry were adopted to detect proliferation 
and apoptosis of MCF-7 cells respectively. Results showed that 
cell proliferation had no significant difference between the non-
specific siRNA transfected MCF-7 cell and control group. However, 
proliferation of survivin siRNA transfected cells was significantly 
suppressed (Figure 3). Annexin and PI staining was detected by 
flow cytometry, we found that the proportion of both early apoptosis 
(Annexin positive and PI negative) and late apoptosis (Annexin and 
PI double positive) in survivin siRNA transfected MCF-7 cells was 
significantly higher than control group (Figure 4). 
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Figure 3. Effect of survivin siRNA on cell proliferation.
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Figure 4. Effect of survivin siRNA on cell apoptosis.
(A)Cell apoptosis was detected by Annexin and PI staining after transfection; 
(B)Cells in different stage of apoptosis was counted, *P < 0.05.
3.4. Effect of survivin siRNA on MCF-7 cells migration and 
invasion 
  Compared with control group, cells migration and invasion did 
not change after tranfected with non-specific siRNA, but greatly 
inhibited after the expression of survivin was interfered (Figure 
5A). The number of cells got through membrane were significantly 
decreased in non-coated and matrigel-coated tranwell assays (Figure 
5B).
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Figure 5. Effect of survivin siRNA on cell migration and invasion of MCF-7.
(A) Cell migration and invasion was measured by transwell assay. (B) The 
number of migration and invasion cells, compared with control group, *P < 
0.05.
4. Discussion
  Eventually clearance of tumor cells is depends on the specific 
immune response, however, the immunogenicity of tumor antigen 
on tumor cells is always weak, which cannot effectively induce 
antitumor immune response[6]. Apoptosis is a tightly regulated 
programmed cell death which involves a series of biochemical 
events leading to specific cell morphology characteristics and 
ultimately death of cells and always caused by the change of internal 
and external environment, cell death signals also could be triggered 
by genetic regulation. It is widely believed that apoptosis plays a 
negative regulatory role in the occurrence and development process 
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of tumor, suppress the growth of tumor which was strictly regulated 
by pro-apoptosis and anti-apoptosis factors.The occurrence of 
breast cancer is closely related to abnormal cellular proliferation 
and apoptosis. Abnormal expression of proliferation and apoptosis 
related gene is one of the crucial factors in the process of tumor 
development[7,8]. 
  Survivin is a powerful apoptosis inhibitor in the IAP family, 
performing its function by inhibiting the activity of caspase3 and 
caspase7 or block the inhibition of SMAC/Biablo to XIAP. Over-
expression of survivin can suppress the process of cell apoptosis, 
resulting in abnormal proliferation. Survivin almost has no 
expression in normal tissues, but highly expressed in a variety of 
tumor cells, and was positively correlated[9-11] with prognosis of 
cancer. This study also found that survivin was expressed in breast 
cancer cell line MDA-MB-231, MDA-MB435, MDA-MB-468, 
MCF-7 and SKBR3 were expressed, especially in MCF-7, which 
was consistent with domestic and foreign researches[12].
  Small interfering RNA (siRNA) interferes with the expression of 
specific genes by targeting homologous mRNA intracellular and 
causing degradation of mRNA before translation. RNAi interference 
is a simple and effective alternative gene knockout technology with 
the advantages of high stability, strong inhibition, and has been an 
ideal tool for enzyme gene therapy better than antisense nucleic 
acid and ribozyme gene therapy[13,14]. Xu[15] established survivin 
adenoviral siRNA vectors and transfected in hepatoma cells HepG2, 
survivin mRNA and protein expression was significantly inhibited, 
cellular apoptosis was found to be strongly promoted.
  Survivin siRNA1 and survivin siRNA2 was applied in therapy of 
osteosarcoma cells MG-63 by Zhao QH and his colleagues[16], they 
found apoptosis of tumor cells was significantly increased. Similar 
results were observed in the present study, survivin siRNA can 
inhibit cell proliferation and induce apoptosis in the breast cancer 
cell line MCF-7. In addition, we also found that survivin siRNA 
resulted in the inhibition of migration and invasion of MCF-7 cells. 
These findings indicated that inhibition the expression of survivin 
might be a potential target for cancer genetic therapy.
  Above all, the basically cause of tumor is the losing of normal 
precise control of cell-cycle at the gene level. In the present study, 
we found survivin was highly expressed in breast cancer cell line 
MCF-7, and the silencing of survivin promoted tumor cell apoptosis, 
inhibited tumor cell migration and invasion. Therefore, we speculate 
gene therapy combined with traditional surgery might get better 
therapeutic effect.
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